Erectile Dysfunction Treatment Erectile Dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during...Read More
Erectile Dysfunction Treatment Market
Erectile Dysfunction (ED) is a male sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. The cause of erectile dysfunction may be physical or psychological. The most common physical causes are related to circulation and blood pressure such as atherosclerosis, hypertension, and diabetes. Psychological causes include anxiety, depression, and stress. The most common treatments for erectile dysfunction are oral therapies such as phosphodiesterase inhibitors (Viagra, Levitra, Cialis), penile injections (alprostadil), penile implants, and vacuum devices. These treatments are effective in 70-80% of men with erectile dysfunction. The global erectile dysfunction treatment market is expected to reach USD 4.3 billion by 2022 from USD 2.5 billion in 2017, at a CAGR of 10.0%.
The erectile dysfunction treatment market is segmented by therapy, product, and geography. Based on therapy, the market is segmented into oral therapy, local therapy, and surgery. Oral therapy is further classified into phosphodiesterase inhibitors and testosterone replacement therapy. Local therapy is further divided into intracavernous alprostadil injections and topical therapy. The surgery segment includes penile implants and penile prosthesis. The products segment includes Viagra, Levitra, Stendra/Spedra, Cialis, Muse, Caverject, Edex/Viridal, Androgel, Testim, Androderm, Fortesta, and Axiron. Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is further divided into the US and Canada. Europe is further classified into Germany, France, Italy, Spain, and the UK. Asia Pacific is further divided into Japan, China, India, South Korea, and Australia. Latin America is further divided into Brazil, Mexico, and Rest of Latin America. The Middle East & Africa is further classified into GCC, South Africa, and Rest of the Middle East & Africa.
The erectile dysfunction treatment market is a highly competitive market with the presence of several major players. These players are focusing on product launches, expansions, and agreements to gain a competitive edge in the market. The key players in this market are Pfizer, Inc. (US), Eli Lilly and Company (US), Bayer AG (Germany), Johnson & Johnson Services, Inc. (US), Endo International plc (Ireland), GlaxoSmithKline plc (UK), Abbott Laboratories (US), Takeda Pharmaceutical Company Limited (Japan), Apricus Biosciences, Inc. (US), Ansell Healthcare LLC (US), Boston Scientific Corporation (US), Coloplast A/S (Denmark), and Cook Medical, Inc. (US).